<DOC>
	<DOC>NCT02385032</DOC>
	<brief_summary>The purpose of this study is to evaluate bioavailability of two formulations of ursodiol.</brief_summary>
	<brief_title>Comparative Bioavailability Study of UDCA</brief_title>
	<detailed_description />
	<mesh_term>Ursodeoxycholic Acid</mesh_term>
	<criteria>BMI ≥ 19.0 and ≤ 30.0 kg/m2. No clinically significant findings in a 12lead electrocardiogram (ECG) Be informed of the nature of the study and give written consent prior to any study procedure Known history or presence of any clinically significant medical condition Participated in a clinical trial which involved administration of an investigational medicinal product within 30 days prior to drug administration, or recently participated in a clinical investigation that, in the opinion of the investigator, would jeopardize subject safety or the integrity of the study results</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>